Clinical trials: Cardiac Allograft Vasculopathy, open to volunteers
Cardiac Allograft Vasculopathy, Heart Transplant
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation
Cardiac allograft vasculopathy is a common complication affecting heart transplant patients. This condition causes narrowing of the heart arteries leading to graft dysfunction.
- Trial name
- NCT04770012
- Testing
- aspirin, Clopidogrel
- Where
- 3 sites in Canada
- Volunteers
- 135 people
- Sponsor
- Ottawa Heart Institute Research Corporation
Cardiac Allograft Vasculopathy
MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation
Cardiac allograft vasculopathy (CAV) is a common complication affecting heart transplant patients. This condition causes narrowing of the heart arteries leading to graft dysfunction.
- Trial name
- NCT06089486
- Testing
- ICA, PET
- Where
- 5 sites in Canada
- Volunteers
- 576 people
- Sponsor
- Ottawa Heart Institute Research Corporation
Cardiac Allograft Vasculopathy
Comparing PCCT With ICA and IVUS in Detecting Cardiac Allograft Vasculopathy
In traditional coronary artery disease, patients often experience symptoms such as angina. However, heart transplant patients lack nerve connections in the transplanted heart and therefore usually do not notice any symptoms.
- Trial name
- CAVIAR (NCT07020039)
- Where
- Sweden
- Volunteers
- 100 people
- Sponsor
- Sahlgrenska University Hospital
Cardiac Allograft Vasculopathy
Physiologic Assessment of Microvascular Function in Heart Transplant Patients
The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on…
- Trial name
- NCT02798731
- Where
- South Korea
- Volunteers
- 200 people
- Sponsor
- Samsung Medical Center